qpatch automated patch-clamp platform (Sophion Bioscience)
Structured Review

Qpatch Automated Patch Clamp Platform, supplied by Sophion Bioscience, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/automated+patch+clamp+qpatch/qpatch+16+automated+electrophysiology+platform/pmc11808707-32-55-59
Average 90 stars, based on 1 article reviews
Images
1) Product Images from "Analgesia and peripheral c-fiber modulation by selective Na v 1.8 inhibition in rhesus"
Article Title: Analgesia and peripheral c-fiber modulation by selective Na v 1.8 inhibition in rhesus
Journal: Pain
doi: 10.1097/j.pain.0000000000003404
Figure Legend Snippet: Na v channel compound profile assessed on the Qube or Qpatch*. Ten-point titrations in the Qube automated patch-clamp assay determined MSD199 to be a potent and selective compound (IC 50 = 4.7 ± 0.8 nM, mean ± SD). MSD199 potency was too weak to calculate for all other Na v isoforms except Na v 1.4, which was 1781-fold shifted to 8370 nM mean IC 50 ± 1429.
Techniques Used: Patch Clamp
Related Articles
Patch Clamp:Article Title: Termination of Vernakalant-Resistant Atrial Fibrillation by Inhibition of Small-Conductance Ca 2+ -Activated K + Channels in Pigs Article Snippet: In Vitro Electrophysiology Effects of AP14145 on hSK3 (KCa2.3) and hERG (hKV11.1) were investigated by automated Article Title: Rational Engineering Defines a Molecular Switch That Is Essential for Activity of Spider-Venom Peptides against the Analgesics Target NaV1.7. Article Snippet: Many spider-venom peptides are known to modulate the activity of the voltage-gated sodium (NaV) subtype 1.7 (NaV1.7) channel, which has emerged as a promising analgesic target.. In particular, a class of spider-venom peptides (NaSpTx1) has been found to potently inhibit NaV1.7 (nanomolar IC50), and has been shown to produce analgesic effects in animals.. However, one member of this family [m-TRTX-Hhn2b (Hhn2b)] does not inhibit mammalian NaV channels expressed in dorsal root ganglia at concentrations up to 100 mM. Article Title: Reply to: How Many SARS-CoV-2 "Viroporins" Are Really Ion Channels? Article Snippet: Using an automated patch clamp technique with gigaseal formation and Stable Transfection:Article Title: Termination of Vernakalant-Resistant Atrial Fibrillation by Inhibition of Small-Conductance Ca 2+ -Activated K + Channels in Pigs Article Snippet: In Vitro Electrophysiology Effects of AP14145 on hSK3 (KCa2.3) and hERG (hKV11.1) were investigated by automated Article Title: Rational Engineering Defines a Molecular Switch That Is Essential for Activity of Spider-Venom Peptides against the Analgesics Target NaV1.7. Article Snippet: Many spider-venom peptides are known to modulate the activity of the voltage-gated sodium (NaV) subtype 1.7 (NaV1.7) channel, which has emerged as a promising analgesic target.. In particular, a class of spider-venom peptides (NaSpTx1) has been found to potently inhibit NaV1.7 (nanomolar IC50), and has been shown to produce analgesic effects in animals.. However, one member of this family [m-TRTX-Hhn2b (Hhn2b)] does not inhibit mammalian NaV channels expressed in dorsal root ganglia at concentrations up to 100 mM. Article Title: Reply to: How Many SARS-CoV-2 "Viroporins" Are Really Ion Channels? Article Snippet: Using an automated patch clamp technique with gigaseal formation and Expressing:Article Title: Termination of Vernakalant-Resistant Atrial Fibrillation by Inhibition of Small-Conductance Ca 2+ -Activated K + Channels in Pigs Article Snippet: In Vitro Electrophysiology Effects of AP14145 on hSK3 (KCa2.3) and hERG (hKV11.1) were investigated by automated Article Title: Rational Engineering Defines a Molecular Switch That Is Essential for Activity of Spider-Venom Peptides against the Analgesics Target NaV1.7. Article Snippet: Many spider-venom peptides are known to modulate the activity of the voltage-gated sodium (NaV) subtype 1.7 (NaV1.7) channel, which has emerged as a promising analgesic target.. In particular, a class of spider-venom peptides (NaSpTx1) has been found to potently inhibit NaV1.7 (nanomolar IC50), and has been shown to produce analgesic effects in animals.. However, one member of this family [m-TRTX-Hhn2b (Hhn2b)] does not inhibit mammalian NaV channels expressed in dorsal root ganglia at concentrations up to 100 mM. Article Title: Reply to: How Many SARS-CoV-2 "Viroporins" Are Really Ion Channels? Article Snippet: Using an automated patch clamp technique with gigaseal formation and Control:Article Title: Termination of Vernakalant-Resistant Atrial Fibrillation by Inhibition of Small-Conductance Ca 2+ -Activated K + Channels in Pigs Article Snippet: In Vitro Electrophysiology Effects of AP14145 on hSK3 (KCa2.3) and hERG (hKV11.1) were investigated by automated Article Title: Rational Engineering Defines a Molecular Switch That Is Essential for Activity of Spider-Venom Peptides against the Analgesics Target NaV1.7. Article Snippet: Many spider-venom peptides are known to modulate the activity of the voltage-gated sodium (NaV) subtype 1.7 (NaV1.7) channel, which has emerged as a promising analgesic target.. In particular, a class of spider-venom peptides (NaSpTx1) has been found to potently inhibit NaV1.7 (nanomolar IC50), and has been shown to produce analgesic effects in animals.. However, one member of this family [m-TRTX-Hhn2b (Hhn2b)] does not inhibit mammalian NaV channels expressed in dorsal root ganglia at concentrations up to 100 mM. Article Title: Reply to: How Many SARS-CoV-2 "Viroporins" Are Really Ion Channels? Article Snippet: Using an automated patch clamp technique with gigaseal formation and In Vitro:Article Title: Termination of Vernakalant-Resistant Atrial Fibrillation by Inhibition of Small-Conductance Ca 2+ -Activated K + Channels in Pigs Article Snippet: In Vitro Electrophysiology Effects of AP14145 on hSK3 (KCa2.3) and hERG (hKV11.1) were investigated by automated Article Title: Rational Engineering Defines a Molecular Switch That Is Essential for Activity of Spider-Venom Peptides against the Analgesics Target NaV1.7. Article Snippet: Many spider-venom peptides are known to modulate the activity of the voltage-gated sodium (NaV) subtype 1.7 (NaV1.7) channel, which has emerged as a promising analgesic target.. In particular, a class of spider-venom peptides (NaSpTx1) has been found to potently inhibit NaV1.7 (nanomolar IC50), and has been shown to produce analgesic effects in animals.. However, one member of this family [m-TRTX-Hhn2b (Hhn2b)] does not inhibit mammalian NaV channels expressed in dorsal root ganglia at concentrations up to 100 mM. Article Title: Reply to: How Many SARS-CoV-2 "Viroporins" Are Really Ion Channels? Article Snippet: Using an automated patch clamp technique with gigaseal formation and Modification:Article Title: Termination of Vernakalant-Resistant Atrial Fibrillation by Inhibition of Small-Conductance Ca 2+ -Activated K + Channels in Pigs Article Snippet: In Vitro Electrophysiology Effects of AP14145 on hSK3 (KCa2.3) and hERG (hKV11.1) were investigated by automated Article Title: Rational Engineering Defines a Molecular Switch That Is Essential for Activity of Spider-Venom Peptides against the Analgesics Target NaV1.7. Article Snippet: Many spider-venom peptides are known to modulate the activity of the voltage-gated sodium (NaV) subtype 1.7 (NaV1.7) channel, which has emerged as a promising analgesic target.. In particular, a class of spider-venom peptides (NaSpTx1) has been found to potently inhibit NaV1.7 (nanomolar IC50), and has been shown to produce analgesic effects in animals.. However, one member of this family [m-TRTX-Hhn2b (Hhn2b)] does not inhibit mammalian NaV channels expressed in dorsal root ganglia at concentrations up to 100 mM. Article Title: Reply to: How Many SARS-CoV-2 "Viroporins" Are Really Ion Channels? Article Snippet: Using an automated patch clamp technique with gigaseal formation and |